New diabetes guidelines urging tighter control spark debate.

Maintaining that prevailing U.S. guidelines for the treatment of diabetes are not up to 'worldwide standards,' a leading endocrinology group is pushing for clinical practice recommendations of its own. One of the group's key provisions is a call for a more aggressive target for HbA1c levels. It's a target that some experts are calling unrealistic. Get an early look at the new recommendations--and some expert feedback.